Related Experiment Video
Updated: Jan 16, 2026

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
CYR61 Expression Is Induced by IGF1 and Promotes the Proliferation of Prostate Cancer Cells Through the PI3/AKT
Greisha L Ortiz-Hernández1, Carmina Patrick1, Stefan Hinz1
1Department of Population Sciences, Division of Biomarkers of Early Detection and Prevention, Beckman Research Institute of City of Hope, Duarte, CA 91010, USA.
Cysteine-rich angiogenic inducer 61 (CYR61) drives prostate cancer (PCa) progression by interacting with insulin-like growth factor-1 (IGF1). Inhibiting CYR61 reduces PCa cell growth and metastasis, suggesting it as a therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cysteine-rich angiogenic inducer 61 (CYR61) is implicated in prostate cancer (PCa) cell growth.
- The precise role of CYR61 in PCa progression and its interaction with insulin-like growth factor-1 (IGF1) are not fully understood.
Purpose of the Study:
- To investigate the molecular interplay between CYR61 and IGF1 in prostate cancer.
- To determine the effect of CYR61 on PCa cell proliferation, viability, migration, and signaling pathways.
Main Methods:
- CYR61 was silenced using small interfering RNA (siRNA) in PC3, LNCaP, and 22Rv1 prostate cancer cell lines.
- Cell proliferation, viability, colony formation, migration, and signaling pathway activation (PI3K/AKT, MAPK) were assessed.
- The effect of recombinant IGF1 on CYR61 expression and cell proliferation was evaluated.
Main Results:
- CYR61 knockdown significantly reduced proliferation, viability, prostasphere formation, and migration in all tested PCa cell lines.
- CYR61 silencing inhibited the PI3K/AKT signaling pathway but did not affect MAPK activation.
- Recombinant IGF1 treatment increased CYR61 expression and cell proliferation, which was attenuated by PI3K/AKT inhibition.
Conclusions:
- Insulin-like growth factor-1 (IGF1) promotes prostate cancer progression via Cysteine-rich angiogenic inducer 61 (CYR61).
- CYR61 plays a crucial role in PCa cell growth, viability, and metastasis.
- CYR61 represents a potential therapeutic target for inhibiting prostate cancer progression and metastasis.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Mitogens and the Cell Cycle
The Ras Gene
Ras is a...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

